Investigation of Epstein-Barr Virus and Parvovirus B19 DNA in Allogeneic Stem Cell Transplant Patients

類似資料

• Primary Epstein–Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis
  著者:: Matthias Karrasch, 等
  出版事項: (2014-11-01)
• Safety and efficacy of allogeneic bone marrow mesenchymal stem cells for treatment of canine leukopenia induced by canine parvovirus infection
  著者:: Yangqing Tian, 等
  出版事項: (2024-02-01)
• Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
  著者:: Masaaki Hotta, 等
  出版事項: (2018-05-01)
• Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity
  著者:: Serdar Şıvgın, 等
  出版事項: (2013-06-01)
• Soro-epidemiologia do virus de Epstein-Barr (VEB) The seroepidemiology of the Epstein-Barr vírus (EBV)
  著者:: Claudio Sergio Pannuti
  出版事項: (1981-02-01)